James Huang
Hogan Lovells
Articles
CMS issues initial guidance on Drug Price Negotiation Program
USA - March 17 2023 On March 15, 2023, the Centers for Medicare & Medicaid Services (CMS) issued initial guidance on the Drug Price Negotiation Program, which was…
Alice Valder Curran, Melissa Bianchi, Mahmud Brifkani, Ken Choe, Beth Halpern, Ashley Ifeadike, Philip Katz, Katie Kramer, Stuart Langbein, Samantha D. Marshall, Rianna Modi, Kathleen A. Peterson, Allison Pugsley, Beth L. Roberts, Abdie Santiago, Joy Sturm
After the Public Health Emergency: Implications for Medicare and U.S federal health care policies
USA - March 13 2023 On January 30, 2023, the Biden Administration announced that it intends to allow the COVID-19 national emergency and public health emergency…
Mike Dohmann, Ashley Grey, Jessica Robinson Hanna, Lindsey Johnson, Katie Kramer, Rianna Modi
CMS issues Medicare Part B and Part D inflation rebate guidance
USA - February 13 2023 On February 9, 2023, the Centers for Medicare & Medicaid Services (CMS) published two “initial” guidance documents implementing the Medicare Part B…
Alice Valder Curran, Mahmud Brifkani, Ken Choe, Beth Halpern, Katie Kramer, Stuart M. Langbein, Samantha D. Marshall, Rianna Modi, Kathleen A. Peterson, Beth L. Roberts, Abdie Santiago
CMS proposes sweeping changes to regenerative medicine reimbursement framework
USA - August 4 2022 Last month, the Centers for Medicare & Medicaid Services (CMS) released new and significant proposals impacting Medicare coding, coverage, and…
World Stem Cell Summit panel cautions over stepped up HCT/P enforcement, reimbursement issues
USA - June 30 2022 Speaking at the World Stem Cell Summit hosted by the Regenerative Medicine Foundation last week, Hogan Lovells partners Mike Druckman, Stuart Langbein…
Thomas Beimers, Mike Druckman, Sally Gu, Stuart M. Langbein, Sarah Thompson Schick
